Search Results - "Salehomoum, Negar"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression by Rosenberg, Stephen A, Niglio, Scot A, Salehomoum, Negar, Chan, Joseph L.-K, Jeong, Byeong-Seon, Wen, Yu, Li, Jiadong, Fukui, Jami, Chen, Suzie, Shin, Seung-Shick, Goydos, James S

    Published in Translational oncology (01-02-2015)
    “…Abstract Our group has previously reported that the majority of human melanomas (> 60%) express the metabotropic glutamate receptor 1 (GRM1) and that the…”
    Get full text
    Journal Article
  2. 2

    Conventional transanal excision: Current status and role in the era of transanal endoscopic surgery by Salehomoum, Negar M., MD, Nogueras, Juan J., MD, MBA, FACS, FASCRS

    Published in Seminars in colon and rectal surgery (01-03-2015)
    “…Abstract Conventional transanal excision as originally described by Parks has been used for the local excision of both benign and malignant lesions of the…”
    Get full text
    Journal Article
  3. 3

    Implementation of a Synoptic Operative Report for Rectal Cancer: A Mixed-Methods Study by Bidwell, Serena S., Merrell, Sylvia Bereknyei, Poles, Gabriela, Morris, Arden M.

    Published in Diseases of the colon & rectum (01-02-2020)
    “…The National Accreditation Program for Rectal Cancer is a collaborative effort to improve the quality of rectal cancer care, including multidisciplinary…”
    Get full text
    Journal Article
  4. 4

    Abstract LB-40: Inhibition of anchorage-independent growth of melanoma cell lines using Riluzole in combination with PI3 kinase pathway inhibitors by Goydos, James S., Salehomoum, Negar M., Rosenberg, Steve, Chan, Joseph L-K, Wen, Yu

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…We previously reported that the majority of human melanomas express metabotrophic glutamate receptor 1 (GRM1), a cell surface glutamate receptor. We recently…”
    Get full text
    Journal Article
  5. 5

    Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression12 by Rosenberg, Stephen A., Niglio, Scot A., Salehomoum, Negar, Chan, Joseph L.-K., Jeong, Byeong-Seon, Wen, Yu, Li, Jiadong, Fukui, Jami, Chen, Suzie, Shin, Seung-Shick, Goydos, James S.

    Published in Translational oncology (03-03-2015)
    “…Our group has previously reported that the majority of human melanomas (> 60%) express the metabotropic glutamate receptor 1 (GRM1) and that the glutamate…”
    Get full text
    Journal Article